Abstract from “Value Investing, the Sanjay Bakshi Way” by Safal Niveshak Let’s look at this hypothetical stock.
As many of you already know – I am now part of the Dr Wealth team as an Equity Investment Analyst (for about nearly 3 months now).
Key Thesis: Multiple strong moats continues to give this company a winning streak in financialsGrowth factors will depend on extraneous circumstances – including the macro trends of ageing population and increasing reliance on health insurance.Valuations look fair to slightly undervalued right now – we can still wait for a better offer!
Key Thesis: Leading market positions in high-quality product tiers + dedicated distribution infrastructure and resulting in cost advantage + using tech and R&D to achieve efficiency advantages.
“One tiny drop changes everything.” That was the tagline for the now-defunct health-tech firm that claimed to have revolutionized blood testing – testing for over 200 diseases and viruses using a single fingerprick of blood.
Over the last couple of months, I have been trying to study the methods in identifying stocks that go on to become big winners in their industry.
**Part 3 is meant to be an informal assessment of NFLX based on observations and through discussions with people, without precise financial data.